therapeutic 1,363 words KG: NAD+
Contents

NAD+ Boosters for Neurodegeneration

💊 Therapeutic Info
NameNAD+
Key Genes/ProteinsAMPK, CD38, CX43, PARP1, SIRT1, SIRT6
Linked Hypotheses22 hypotheses

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (146)

Circadian Glymphatic Entrainment via Targeted Orexin Recepto
Score: 0.86
AMPK hypersensitivity in astrocytes creates enhanced mitocho
Score: 0.82
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.79
Senescent Microglia Resolution via Maresins-Senolytics Combi
Score: 0.79
Competitive APOE4 Domain Stabilization Peptides
Score: 0.78
SASP-Driven Aquaporin-4 Dysregulation
Score: 0.78
Selective HDAC3 Inhibition with Cognitive Enhancement
Score: 0.78
Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu
Score: 0.77
Chromatin Accessibility Restoration via BRD4 Modulation
Score: 0.77
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.76
SASP-Mediated Cholinergic Synapse Disruption
Score: 0.76
Circadian Clock-Autophagy Synchronization
Score: 0.76
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.76
Transcriptional Autophagy-Lysosome Coupling
Score: 0.76
Multi-Modal Stress Response Harmonization
Score: 0.76
Senescence-Activated NAD+ Depletion Rescue
Score: 0.76
Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.75
Circadian-Synchronized Proteostasis Enhancement
Score: 0.74
Smartphone-Detected Motor Variability Correction
Score: 0.74
Senescent Cell Mitochondrial DNA Release
Score: 0.74
pg 1/8Next →

Related Analyses (29)

Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived

Related Experiments (30)

FK866 treatment in DSS-induced colitis mouse model
validation · proposed · Score: 0.90
NAD depletion effects on monocyte/macrophage differentiation
exploratory · proposed · Score: 0.90
Germfree mouse colonocyte energy metabolism analysis
validation · proposed · Score: 0.90
FK866 in azoxymethane/DSS colitis-associated cancer model
validation · proposed · Score: 0.85
Sirtuin Pathway Dysfunction Validation in Parkinson's Diseas
clinical · proposed · Score: 0.40

See Also (15)

Olfactory Mucosa, Blood and Urine for Identification of
clinical · Pages share 139 hypotheses
China Neurodegeneration Epidemiology
disease · Pages share 139 hypotheses
Neuroimaging for Parkinsonian Syndromes (NCT03872102)
clinical · Pages share 27 hypotheses
Synaptic Biomarkers in Neurodegeneration
biomarker · Pages share 139 hypotheses
Swedish BioFINDER 2 Study: Biomarkers and Neurodegenera
clinical · Pages share 139 hypotheses

Knowledge Graph (12 edges)

NAD+ activates SIRT1
AMPK contributes_to NAD+
NAD+ regulates SIRT1
NAD+ modulates SIRT1
CD38 depletes NAD+
PARP degrades NAD+
SIRT degrades NAD+
NAD+ protects_against BLOOD-BRAIN BARRIER DAMAGE
NAD+ associated_with Cellular Processes
NAD+ modulates inflammation

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.